Abstract
Despite the high prevalence of thyroid diseases in the general population, male reproductive function in patients with thyroid disease has been the subject of only a few studies. Hyperthyroidism appears to cause sperm abnormalities (mainly reduction in motility), which reverse after restoration of euthyroidism. Radioiodine therapy for hyperthyroidism or thyroid cancer may cause transient reductions in sperm count and motility, but there appears to be little risk of permanent effects provided that the cumulative dose is less than 14 MBq. The effects of hypothyroidism on male reproduction appear to be more subtle than those of hyperthyroidism and reversible. Severe, prolonged hypothyroidism in childhood may be associated with permanent abnormalities in gonadal function.
Similar content being viewed by others
References
Winters S.J., Berga S.L. Gonadal dysfunction in patients with thyroid disorders. Endocrinologist 1997, 7: 167–173.
Shetty A., Wilber J.F. Pituitary-thyroid hormone interactions in states of hyper- and hypothyroidism: Clinical implications in 2000. Endocrinologist 2000, 10: 118–123.
Jannini E.A., Ulisse S., D’Armiento M. Thyroid hormone and male gonadal function. Endocr. Rev. 1995, 16: 443–459.
Jannini E.A., Crescenzi A., Rucci N., et al. Ontogenetic pattern of thyroid hormone receptor expression in the human testis. J. Clin. Endocrinol. Metab. 2000, 85: 3453–3457.
Olivo J., Southren A.L., Gordon G.G., Tochimoto S. Studies of the protein binding of testosterone in plasma in disorders of thyroid function: effect of therapy. J. Clin. Endocrinol. Metab. 1970, 31: 539–545.
Ruder H., Corvol P., Mahoudeau J.A., Ross G.T., Lipsett M.B. Effects of induced hyperthyroidism on steroid metabolism in man. J. Clin. Endocrinol. Metab. 1971, 33: 382–387.
Ford H.C., Cooke R.R., Keightley E.A., Feek C.M. Serum levels of free and bound testosterone in hyperthyroidism. Clin. Endocrinol. (Oxf.) 1992, 36: 187–192.
Gordon G.G., Southren A.L., Tochimoto S., Rand J.J., Olivo J. Effect of hyperthyroidism and hypothyroidism on the metabolism of testosterone and androstenedione in man. J. Clin. Endocrinol. Metab. 1969, 29: 164–170.
Vermeulen A., Verdonck L., Van Der Straeten M., Orie N. Capacity of the testosterone-binding globulin in human plasma and influence of specific binding to testosterone on its metabolic clearance rate. J. Clin. Endocrinol. Metab. 1969; 29: 1470–1480.
Kidd G.S., Glass A.R., Vigersky R.A. The hypothalamic-pituitary-testicular axis in thyrotoxicosis. J. Clin. Endocrinol. Metab. 1979, 48: 798–802.
Chopra I.J., Tulchinsky D. Status of estrogen-androgen balance in hyperthyroid men with Graves’ disease. J. Clin. Endocrinol. Metab. 1974, 38: 269–277.
Ridgway E.C., Maloof F., Longcope C. Androgen and oestrogen dynamics in hyperthyroidism. J. Endocrinol. 1982, 95: 105–115.
Gallagher T.F., Fukushima D.K., Noguchi S., et al. Recent studies in steroid hormone metabolism in man. Recent Prog. Horm. Res. 1966, 22: 283–303.
Longcope C. Methods and results of aromatization studies in vivo. Cancer Res. 1982, 42 (8): 3307s-3311s.
Nomura K., Suzuki H., Saji M., et al. High serum progesterone in hyperthyroid men with Graves’ disease. J. Clin. Endocrinol. Metab. 1988, 66: 230–232.
Abalovich M., Levalle O., Hermes R., et al. Hypothalamicpituitary- testicular axis and seminal parameters in hyperthyroid males. Thyroid 1999, 9: 857–863.
Michnovicz J.J., Galbraith R.A. Effects of exogenous thyroxine on C-2 and C-16 alpha hydroxylations of estradiol in humans. Steroids 1990, 55: 22–26.
Carlson H.E. Current concepts — gynecomastia. N. Engl. J. Med. 1980, 303: 795–799.
Rojdmark S., Berg A., Kallner G. Hypothalamic-pituitarytesticular axis in patients with hyperthyroidism. Horm. Res. 1988, 29: 185–190.
Wortsman J., Rosner W., Dufau M.L. Abnormal testicular function in men with primary hypothyroidism. Am. J. Med. 1987, 82: 207–212.
Jaya Kumar B., Khurana M.L., Ammini A.C., Karmarkar M.G., Ahuja M.M. Reproductive endocrine functions in men with primary hypothyroidism: effect of thyroxine replacement. Horm. Res. 1990, 34: 215–218.
Velazquez E.M., Bellabarba Arata G. Effects of thyroid status on pituitary gonadotropin and testicular reserve in men. Arch. Androl. 1997, 38: 85–92.
Clyde H.R., Walsh P.C., English R.W. Elevated plasma testosterone and gonadotropin levels in infertile males with hyperthyroidism. Fertil. Steril. 1976, 27: 662–666.
Hudson R.W., Edwards A.L. Testicular function in hyperthyroidism. J. Androl. 1992, 13: 117–124.
Krassas G.E., Pontikides N., Deligianni V., Miras K. A prospective controlled study of the impact of hyperthyroidism on reproductive function in males. J. Clin. Endocrinol. Metab. 2002, 87: 3667–3671.
Dunn J.T. Choice of therapy in young adults with hyperthyroidism of Graves’ disease. A brief, case-directed poll of fiftyfour thyroidologists. Ann. Intern. Med. 1984, 100: 891–893.
Kaplan M.M., Meier D.A., Dworkin H.J. Treatment of hyperthyroidism with radioactive iodine. Endocrinol. Metab. Clin. North. Am. 1998, 27: 205–223.
Hyer S., Vini L., O’Connell M., Pratt B., Harmer C. Testicular dose and fertility in men following 131I therapy for thyroid cancer. Clin. Endocrinol. (Oxf.) 2002, 56: 755–758.
Mussey R.D. The thyroid gland and pregnancy. Am. J. Obstet. Gynecol. 1938, 36: 529–538.
Krassas G.E. Thyroid disease and female reproduction. Fertil. Steril. 2000, 74: 1063–1070.
Handelsman D.J., Turtle J.R. Testicular damage after radioactive iodine (I-131) therapy for thyroid cancer. Clin. Endocrinol. (Oxf.) 1983, 18: 465–472.
Starr P., Jaffe H.L., Oettinger L. Jr. Later results of 131-I treatment of hyperthyroidism in 73 children and adolescents: 1967 follow-up. J. Nucl. Med. 1969, 10: 586–590.
Hayek A., Chapman E.M., Crawford J.D. Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine. N. Engl. J. Med. 1970, 283: 949–953.
Safa A.M., Schumacher O.P., Rodriguez-Antunez A. Longterm follow-up results in children and adolescents treated with radioactive iodine (131-I) for hyperthyroidism. N. Engl. J. Med. 1975, 292: 167–171.
Halnan K.E. Risks from radioiodine treatment of thyrotoxicosis. Br. Med. J. 1983, 287: 1821–1822.
Trunnell J.B., Duffy D.G., Godwin J.T., Peacock W., Kirschner L., Hill R. The distribution of radioactive iodine in human tissues: necropsy study in nine patients. J. Clin. Endocrinol. Metab. 1950, 10: 1007–1021.
Berman M., Braverman L.B., Burke J., et al. Iodine-123, iodine-124, iodine-125, iodine-126, iodine-130, iodine-131 and iodine-132 as sodium iodide MIRD pamphlet no 5. New York: The Society of Nuclear Medicine. 1988.
Erickson B.H. Effect of 60Co gamma radiation on the stem and differentiating spermatogonia of the postpuberal rat. Radiat. Res. 1976, 68: 433–448.
Mian T.A., Suzuki N., Glenn H.J., Haynie T.P., Meistrich M.L. Radiation damage to mouse testis cells from [99mTc] pertechnetate. J. Nucl. Med. 1977, 18: 1116–1122.
Lushbaugh C.C., Casarett G.W. The effects of gonadal irradiation in clinical radiation therapy: a review. Cancer 1976, 37 (2): 1111–1125.
Gorman C.A. Radioiodine and pregnancy (Review). Thyroid 1999, 9: 721–726.
Handelsman D.J., Conway A.J., Donnelly P.E., Turtle J.R. Azoospermia after iodine-131 treatment for thyroid carcinoma. Br. Med. J. 1980, 281: 1527.
Edmonds C.J., Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br. J. Radiol. 1986, 59: 45–51.
Pacini F., Gasperi M., Fugazzola L., et al. Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine. J. Nucl. Med. 1994, 35: 1418–1422.
Wichers M., Benz E., Palmedo H., Biersack H.J., Grunwald F., Klingmuller D. Testicular function after radioiodine therapy for thyroid carcinoma. Eur. J. Nucl. Med. 2000, 27: 503–507.
Wartofsky L. Thyroid cancer. Humana Press, Totowa, New Jersey, 2000.
Tunbridge W.M.G., Evered D., Hall R., et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. (Oxf.) 1977, 7: 481–493.
Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 2000, 160: 526–534.
Delange F. The disorders induced by iodine deficiency. Thyroid 1994, 41: 107–128.
Kolettis P.N., Sabanegh E.S. Significant medical pathology discovered during a male infertility evaluation. J. Urol. 2001, 166: 178–180.
Trummer H., Ramschak-Schwarzer S., Haas J., Habermann H., Pummer K., Leb G. Thyroid hormones and thyroid antibodies in infertile males. Fertil. Steril. 2001, 76: 254–257.
Vulsma T., Gons M.H., de Vijlder J.J.M. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N. Engl. J. Med. 1989, 321: 13–16.
Longcope C. The male and female reproductive systems in hypothyroidism. In: Braverman L.E., Utiger R.D. (Eds.) Werner & Ingbar’s The thyroid: A fundamental and clinical text, 8th edition. Lippincott Williams & Wilkins, Philadelphia, 2000, P. 824.
Salerno M., Micillo M., Di Maio S., et al. Longitudinal growth, sexual maturation and final height in patients with congenital hypothyroidism detected by neonatal screening. Eur. J. Endocrinol. 2001, 145: 377–383.
Dickerman Z., De Vries L. Prepubertal and pubertal growth, timing and duration of puberty and attained adult height in patients with congenital hypothyroidism (CH) detected by the neonatal screening programme for CH — a longitudinal study. Clin. Endocrinol. (Oxf.) 1997, 47: 649–654.
Hanna C.E., LaFranchi S.H. Adolescent thyroid disorders. Adolesc. Med. 2002, 13: 13–36.
Kendle F. Case of precocious puberty in a female cretin. Br. Med. J. 1905, 1: 246–248.
Panidis D.K., Rousso D.H. Macro-orchidism in juvenile hypothyroidism. Arch. Androl. 1999, 42: 85–87.
Grossman M., Weintraub B.D., Szkudlinski M.W. Novel insights into the molecular mechanisms of human thyrotropin action: structural, physiological, and therapeutic implications for the glycoprotein hormone family. Endocr. Rev. 1997, 18: 476–501.
Corrales Hernandez J.J., Miralles Garcia J.M., Garcia Diez L.C. Primary hypothyroidism and human spermatogenesis. Arch. Androl. 1990, 25: 21–27.
Cavaliere H., Abelin N., Medeiros-Neto G. Serum levels of total testosterone and sex hormone binding globulin in hypothyroid patients and normal subjects treated with incremental doses of L-T4 or L-T3. J. Androl. 1988, 9: 215–219.
Tagawa N., Takano T., Fukata S., et al. Serum concentration of androstenediol and androstenediol sulfate in patients with hyperthyroidism and hypothyroidism. Endocr. J. 2001, 48: 345–354.
Donnelly P., White C. Testicular dysfunction in men with primary hypothyroidism; reversal of hypogonadotrophic hypogonadism with replacement thyroxine. Clin. Endocrinol. (Oxf.) 2000, 52: 197–201.
Horvath E., Kovacs K., Scheithauer B.W. Pituitary hyperplasia. Pituitary 1999, 1: 169–179.
Kocova M., Netkov S., Sukarova-Angelovska E. Pituitary pseudotumor with unusual presentation reversed shortly after the introduction of thyroxine replacement therapy. J. Pediatr. Endocrinol. Metab. 2001, 14: 1665–1669.
Honbo K.S., Van Herle A.J., Kellett K.A. Serum prolactin levels in untreated primary hypothyroidism. Am. J. Med. 1978, 64: 782–787.
Notsu K., Ito Y., Furuya H., Ohguni S., Kato Y. Incidence of hyperprolactinemia in patients with Hashimoto’s thyroiditis. Endocr. J. 1997, 44: 89–94.
Griboff S.I. Semen analysis in myxedema. Fertil. Steril. 1962, 13: 436–443.
De la Balze E.A., Arrilaga F, Mancini R.E., Janches M., Davidson O.W., Gurtman A.I. Male hypogonadism in hypothyroidism: a study of six cases. J. Clin. Endocrinol. Metab. 1962, 22: 212–222.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krassas, G.E., Perros, P. Thyroid disease and male reproductive function. J Endocrinol Invest 26, 372–380 (2003). https://doi.org/10.1007/BF03345187
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345187